Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BNP--Considering a heartfelt message.

Ken Sikaris1

  • 1Department of Chemical Pathology, Melbourne Pathology, Collingwood, Melbourne, Vic., Australia. ken.sikaris@mps.com.au

Heart, Lung & Circulation
|December 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Definitions and major prerequisites of direct and indirect approaches for estimating reference limits.

Clinical chemistry and laboratory medicine·2022
Same author

Current Utility and Reliability of Biological Variability.

Clinical chemistry·2021
Same author

Differing performance of two assays for the measurement of anti-Mullerian hormone in premenopausal women: A cross-sectional study.

Clinical endocrinology·2021
Same author

Machine Learning for Clinical Chemists.

Clinical chemistry·2019
Same author

Results of the first recorded evaluation of a national gestational diabetes mellitus register: Challenges in screening, registration, and follow-up for diabetes risk.

PloS one·2018
Same author

Distinguishing reference intervals and clinical decision limits - A review by the IFCC Committee on Reference Intervals and Decision Limits.

Critical reviews in clinical laboratory sciences·2018
Same journal

Diabetes and Risk of Radial Artery Occlusion After Distal Radial Access: Insights From the KODRA Registry.

Heart, lung & circulation·2026
Same journal

Smartwatch-Based Heart Rate Detection in Atrial, Ventricular and Pulseless Arrhythmias.

Heart, lung & circulation·2026
Same journal

Global, Regional and National Burden of Pulmonary Arterial Hypertension in Young and Middle-Aged Adults, 1990-2021, with Projections to 2045.

Heart, lung & circulation·2026
Same journal

2026 Update of the Core Components of Cardiovascular Rehabilitation: A Position Statement From the Australian Cardiovascular Health and Rehabilitation Association (ACRA).

Heart, lung & circulation·2026
Same journal

Outcomes Selected by Pressure Wire in Coronary Artery Revascularisation: The OSCAR Study.

Heart, lung & circulation·2026
Same journal

Coagulopathy in Cardiac Surgery: A Scoping Review of Prothrombin Complex Concentrate.

Heart, lung & circulation·2026
See all related articles

Brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are valuable clinical tests for diagnosing and monitoring heart failure. While useful for high-risk patients, their role as a general screening test for cardiac events remains limited.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Natriuretic hormones, including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), are key mediators in the cardiac response to volume overload and mechanical dysfunction.
  • BNP and its cleavage product, N-terminal proBNP (NT-proBNP), serve as crucial biomarkers in cardiovascular medicine.

Purpose of the Study:

  • To evaluate the clinical utility of BNP and NT-proBNP as diagnostic and monitoring tools for cardiac conditions.
  • To assess the predictive value of BNP in cardiac events and mortality.

Main Methods:

  • Review of existing physiological and clinical data on natriuretic peptides.
  • Analysis of the diagnostic and prognostic performance of BNP and NT-proBNP tests.

Main Results:

Related Experiment Videos

  • BNP and NT-proBNP exhibit significant similarities, making them both highly useful clinical tests.
  • These biomarkers are valuable for diagnosing high-risk patients, such as those with dyspnea, and for monitoring heart failure treatment.
  • Normal BNP levels can predict cardiac events and mortality, but evidence for their use as a general screening test is limited.

    • Conclusions:

    • BNP and NT-proBNP are effective tools for the diagnosis and management of heart failure.
    • Further research may clarify the role of natriuretic peptides in broader cardiovascular screening strategies.